BioSpace News Archive

Deals

ArQule Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

ArQule, Inc. announced the closing of its previously announced underwritten public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,650,000 shares at the public offering price of $5.50 per share.

July 13, 2018
·
4 min read
Global Generic Drugs Market 2018-2022| Availability of Low-cost Alternatives to Promote Growth| Technavio

The global generic drugs market is expected to post a CAGR of more than 10% during the period 2018-2022, according to the latest market research report by Technavio.

July 13, 2018
·
4 min read
Business

Torchmark Corporation Announces Second Quarter 2018 Earnings Release And Conference Call

Torchmark Corporation will release Second Quarter 2018 earnings after the market closes on Wednesday, July 25, 2018.

July 13, 2018
·
1 min read
Policy

Indivior Is Granted Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film

Indivior PLC announced that the U.S. District Court for the District of New Jersey has granted a preliminary injunction (PI) against Dr. Reddy’s Laboratories (DRL).

July 13, 2018
·
13 min read
Business

Dr. Joshua Hare To Present Longeveron Regenerative Stem Cell Research At The Sixth Annual Aspen BrainLab

Longeveron LLC announced that Dr. Joshua Hare, Chief Science Officer, will present at the sixth annual Aspen BrainLab on July 14.

July 13, 2018
·
2 min read
FDA

FDA approves the first drug with an indication for treatment of smallpox

The U.S. Food and Drug Administration today approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox.

July 13, 2018
·
3 min read
Policy

Hawaii Health Measure Includes Last-Minute Provision Benefiting Big Tobacco; Legislature Should Revisit Measure and Repair the Damage

Joint Statement by Matthew L. Myers, President, Campaign for Tobacco-Free Kids; Harold P. Wimmer, National President and CEO, American Lung Association; Nancy Brown, CEO, American Heart Association

July 13, 2018
·
2 min read
Business

Gilead Sciences to Release Second Quarter 2018 Financial Results on Wednesday, July 25, 2018

Conference Call and Webcast to Follow

July 13, 2018
·
1 min read
Business

Sangamo Therapeutics Announces Technology Leadership Changes

Sangamo Therapeutics, Inc. announced that Michael Holmes, Ph.D., Senior Vice President and Chief Technology Officer, will resign from the Company effective July 20th to pursue an opportunity with a startup biotech company.

July 13, 2018
·
2 min read
Bio NC

New Study Highlights Emerging Trends in Pharmaceutical Medical Education Program Creation and Delivery

Medical education plays an essential role in updating physicians and other health care professionals about new treatment options and advances in disease state understanding.

July 13, 2018
·
2 min read